EGFR and lung adenocarcinoma: Some studies showed that curcumin and its analogs can induce EGFR degradation in EGFR-TKI-resistant and -sensitive lung adenocarcinoma cells and sensitize the TKI-resistant NSCLC cells to gefitinib [33, 47, 48].